Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol 19(1):135. https://doi.org/10.1186/s12969-021-00629-8
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol 31(2):390–392
3. Okamoto N, Yokota S, Takei S, OkuraY KT, Shimizu M et al (2018) Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Mod Rheumatol 29(1):41–59. https://doi.org/10.1080/14397595.2018.1514724
4. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482. https://doi.org/10.1002/acr.20460
5. Vanoni F, Minoia F, Malattia C (2017) Biologics in juvenile idiopathic arthritis: a narrative review. Eur J Pediatr 176(9):1147–1153. https://doi.org/10.1007/s00431-017-2960-6